1. Home
  2. PLUG vs NVAX Comparison

PLUG vs NVAX Comparison

Compare PLUG & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLUG
  • NVAX
  • Stock Information
  • Founded
  • PLUG 1997
  • NVAX 1987
  • Country
  • PLUG United States
  • NVAX United States
  • Employees
  • PLUG N/A
  • NVAX N/A
  • Industry
  • PLUG Industrial Machinery/Components
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PLUG Energy
  • NVAX Health Care
  • Exchange
  • PLUG Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • PLUG 1.9B
  • NVAX 2.0B
  • IPO Year
  • PLUG 1999
  • NVAX 1995
  • Fundamental
  • Price
  • PLUG $2.01
  • NVAX $9.22
  • Analyst Decision
  • PLUG Hold
  • NVAX Buy
  • Analyst Count
  • PLUG 26
  • NVAX 6
  • Target Price
  • PLUG $4.99
  • NVAX $17.83
  • AVG Volume (30 Days)
  • PLUG 49.8M
  • NVAX 6.2M
  • Earning Date
  • PLUG 11-12-2024
  • NVAX 11-11-2024
  • Dividend Yield
  • PLUG N/A
  • NVAX N/A
  • EPS Growth
  • PLUG N/A
  • NVAX N/A
  • EPS
  • PLUG N/A
  • NVAX N/A
  • Revenue
  • PLUG $684,486,000.00
  • NVAX $987,667,000.00
  • Revenue This Year
  • PLUG N/A
  • NVAX N/A
  • Revenue Next Year
  • PLUG $43.83
  • NVAX N/A
  • P/E Ratio
  • PLUG N/A
  • NVAX N/A
  • Revenue Growth
  • PLUG N/A
  • NVAX N/A
  • 52 Week Low
  • PLUG $1.60
  • NVAX $3.53
  • 52 Week High
  • PLUG $6.33
  • NVAX $23.86
  • Technical
  • Relative Strength Index (RSI)
  • PLUG 46.40
  • NVAX 35.66
  • Support Level
  • PLUG $1.88
  • NVAX $8.43
  • Resistance Level
  • PLUG $2.62
  • NVAX $9.48
  • Average True Range (ATR)
  • PLUG 0.19
  • NVAX 0.47
  • MACD
  • PLUG -0.01
  • NVAX -0.04
  • Stochastic Oscillator
  • PLUG 17.84
  • NVAX 35.91

About PLUG Plug Power Inc.

Plug Power is building an end-to-end green hydrogen ecosystem—from production, storage, and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets, including material handling, e-mobility, power generation, and industrial applications.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.

Share on Social Networks: